These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25535041)

  • 21. Revised cost estimates of Medicaid recipients with serious mental illness and HIV-AIDS.
    Rothbard AB; Miller K; Lee S; Blank M
    Psychiatr Serv; 2009 Jul; 60(7):974-7. PubMed ID: 19564230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of HIV care for patients with serious mental illness.
    Bogart LM; Fremont AM; Young AS; Pantoja P; Chinman M; Morton S; Koegel P; Sullivan G; Kanouse DE
    AIDS Patient Care STDS; 2006 Mar; 20(3):175-82. PubMed ID: 16548714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of antiretroviral medication adherence among a diverse cohort of adolescents with HIV.
    Chandwani S; Koenig LJ; Sill AM; Abramowitz S; Conner LC; D'Angelo L
    J Adolesc Health; 2012 Sep; 51(3):242-51. PubMed ID: 22921134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study evaluating clinical outcomes and costs of three NNRTI-based HAART regimens in Kerala, India.
    George C; Yesoda A; Jayakumar B; Lal L
    J Clin Pharm Ther; 2009 Feb; 34(1):33-40. PubMed ID: 19125901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.
    Webb MS; Vanable PA; Carey MP; Blair DC
    AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of HIV antiretroviral adherence in persons with serious mental illness.
    Wagner GJ; Kanouse DE; Koegel P; Sullivan G
    AIDS Care; 2004 May; 16(4):501-6. PubMed ID: 15203417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triply-diagnosed patients in the HIV/AIDS Treatment Adherence, Health Outcomes and Cost Study: patterns of home care use.
    Ettner SL; Conover CJ; Proescholdbell RJ; Weaver MR; Ang A; Arno PS;
    AIDS Care; 2008 Nov; 20(10):1177-89. PubMed ID: 18608077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RE: Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults by JM Nachega et al. (2013), TMIH 18, pp 53–57.
    Nakimuli-Mpungu E; Dowdy DW; Nachega JB
    Trop Med Int Health; 2014 Jan; 19(1):133-4. PubMed ID: 24851263
    [No Abstract]   [Full Text] [Related]  

  • 31. RE: Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults by JM Nachega et al. (2013), TMIH 18, pp 53–57.
    Kapoor S
    Trop Med Int Health; 2014 Jan; 19(1):131-2. PubMed ID: 24851262
    [No Abstract]   [Full Text] [Related]  

  • 32. Costs of care for people living with combined HIV/AIDS, chronic mental illness, and substance abuse disorders.
    Conover CJ; Weaver M; Ang A; Arno P; Flynn PM; Ettner SL;
    AIDS Care; 2009 Dec; 21(12):1547-59. PubMed ID: 20024734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe mental illness and retention in anti-retroviral care: a retrospective study.
    Joska JA; Obayemi A; Cararra H; Sorsdahl K
    AIDS Behav; 2014 Aug; 18(8):1492-500. PubMed ID: 24515624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decisional capacity and medication adherence among youth with HIV.
    Chenneville T; Clutter MO; Hintz S; Walsh A; Emmanuel P; Lujan-Zilberman J; Rodriguez C
    AIDS Care; 2015; 27(3):338-41. PubMed ID: 25616658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting HIV care costs using CD4 counts from clinical trials.
    Hill A; Gebo K
    Am J Manag Care; 2007 Sep; 13(9):524-8. PubMed ID: 17803366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir+ritonavir regimens in the CASTLE study.
    Simpson KN; Rajagopalan R; Dietz B
    Adv Ther; 2009 Feb; 26(2):185-93. PubMed ID: 19219410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summaries for patients. Adherence to HIV treatment and costs of care.
    Ann Intern Med; 2010 Jan; 152(1):I-50. PubMed ID: 20048265
    [No Abstract]   [Full Text] [Related]  

  • 39. Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial.
    Cook J; Dasbach E; Coplan P; Markson L; Yin D; Meibohm A; Nguyen BY; Chodakewitz J; Mellors J
    AIDS Res Hum Retroviruses; 1999 Apr; 15(6):499-508. PubMed ID: 10221527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coercion or Caring: The Fundamental Paradox for Adherence Interventions for HIV+ People with Mental Illness.
    Eisenberg MM; Hennessy M; Coviello D; Hanrahan N; Blank MB
    AIDS Behav; 2017 Jun; 21(6):1530-1539. PubMed ID: 27544517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.